Montreal Heart Institute
Clinical trials sponsored by Montreal Heart Institute, explained in plain language.
-
Can a daily aspirin stop heart disease before it starts? a new study aims to find out.
Disease control Not yet recruitingThis pilot study will test whether it is possible to run a larger trial comparing low-dose aspirin to no aspirin in people who have early signs of coronary artery disease but no symptoms. The study will enroll 48 participants and focus on how many people can be recruited and how …
Phase: PHASE3 • Sponsor: Montreal Heart Institute • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
Inhaled drug combo may prevent heart failure during bypass surgery
Disease control Not yet recruitingThis study tests whether giving two inhaled drugs (milrinone and epoprostenol) before heart bypass surgery can prevent the heart's right side from failing. About 141 adults having heart surgery will be randomly assigned to receive the drug combination or a placebo. The goal is to…
Phase: PHASE2 • Sponsor: Montreal Heart Institute • Aim: Disease control
Last updated Apr 22, 2026 15:59 UTC
-
AI boosts heart disease detection in family clinics
Diagnosis Not yet recruitingThis study tests whether an AI tool called DeepECG can help family doctors and nurse practitioners better detect heart problems from electrocardiograms (ECGs). About 2,000 patients will take part, and doctors will gradually start using the AI to see if it improves their ability t…
Phase: NA • Sponsor: Montreal Heart Institute • Aim: Diagnosis
Last updated May 15, 2026 11:57 UTC
-
New tool helps heart patients weigh bleeding vs. clot risks
Knowledge-focused Not yet recruitingThis study tests a patient decision aid (PDA) for people who have had a heart attack, received stents, and are at high risk for both bleeding and blood clots. The PDA helps patients understand their treatment options for blood-thinning medications and make a choice that fits thei…
Phase: NA • Sponsor: Montreal Heart Institute • Aim: Knowledge-focused
Last updated May 17, 2026 03:30 UTC